Evidence map›Paper›PMID 29507226›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells.

Thomas Patzelt, Selina J Keppler, Oliver Gorka, Silvia Thoene, Tim Wartewig, Michael Reth, Irmgard Förster, Roland Lang, Maike Buchner, Jürgen Ruland

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. CD9Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A Novel Forkhead Box Protein P (FoxP) FromFrontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Thomas PatzeltInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Selina J KepplerInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Oliver GorkaInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Silvia ThoeneInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Tim WartewigInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany.
Michael RethInstitute of Biology III (Molecular Immunology), University of Freiburg, 79108 Freiburg, Germany.
Irmgard FörsterImmunology and Environment, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany.
Roland LangMikrobiologisches Institut, Universitätsklinikum Erlangen, 91054 Erlangen, Germany.
Maike BuchnerInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; maike.buchner@tum.de j.ruland@tum.de.
Jürgen RulandInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany; maike.buchner@tum.de j.ruland@tum.de.
Klinikum rechts der Isar · DETechnical University of Munich · DEGerman Cancer Research Center · DEUniversitätsklinikum Erlangen · DEUniversity of Bonn · DEUniversity of Freiburg · DE

Funding

European Research Council 322865
6 · The paper itself

Abstract

The transcription factor Foxp1 is critical for early B cell development. Despite frequent deregulation of Foxp1 in B cell lymphoma, the physiological functions of Foxp1 in mature B cells remain unknown. Here, we used conditional gene targeting in the B cell lineage and report that Foxp1 disruption in developing and mature B cells results in reduced numbers and frequencies of follicular and B-1 B cells and in impaired antibody production upon T cell-independent immunization in vivo. Moreover,

Indexed as

AnimalsAntibodiesAntigens, CD19bcl-X ProteinB-LymphocytesForkhead Transcription FactorsMiceMice, KnockoutMice, TransgenicOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionRepressor ProteinsT-LymphocytesAntibodiesAntigens, CD19Bcl2l1 protein, mousebcl-X ProteinCD19 antigen, mouseForkhead Transcription FactorsFoxp1 protein, mouseRepressor ProteinsB cell quiescenceB cell survivalimmunologytranscriptional regulation

Identifiers

PMID29507226
PMCPMC5866538
OpenAlexW2790412643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.